Skip to content

Clinical trials

Phase 1/2 Peanut Hypersensitivity trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peanut Hypersensitivity Phase: Phase 1/2 Country / region: United States Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20102
20112
20121
20132
20181
20191
20213
20222
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated3
Recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of North Carolina, Chapel Hill4
Alladapt Immunotherapeutics, Inc.2
Johns Hopkins University2
Massachusetts General Hospital2
ALK-Abelló A/S1
Boston Children's Hospital1
Lynda Schneider1
N-Fold, LLC1
National Institute of Allergy and Infectious Diseases (NIAID)1
Scripps Health1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peanut Hypersensitivity17
Food Hypersensitivity8
Hypersensitivity6
Hypersensitivity, Immediate4
Egg Hypersensitivity2
Immune System Diseases2
Milk Hypersensitivity2
Nut Hypersensitivity2
Shellfish Hypersensitivity2
Wheat Hypersensitivity2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.